CGTX

Conviction 18HealthcareScan · Mon, Aug 10, 2026

CGTX$1.06-2.31%

ResistanceSupportVol 14Insider buy

Vol MA14 559.41K

May 11May 28Jun 16Jul 6Jul 23Aug 10

COGNITION THERAPEUTICS INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cogrx.com ↗

Price1.06

Change-2.31%

Gap+0.00%

Rel volume1.71×

Avg volume635.48K

Avg $ vol630.52K

SMA 200.9716

SMA 501.12

SMA 2001.25

Price vs 50-5.96%

Price vs 200-15.78%

MA stackbearish

50/200 cross—

Supertrendup · 0.8636

RSI (14)52

MACD hist0.03

MACD crossbull · 4d

Stoch %K / %D65 / 77

ADX (14)22

+DI / −DI23 / 18

RSI divergenceBullish

MACD divergenceBullish

ATR %+8.05%

ADR %6.98%

52w high3.18

52w low0.5946

From 52w high-66.82%

Above 52w low+77.43%

New 52w highNo

SqueezeOff

Bollinger width26.55%

%B0.82

Donchian pos64.81%

Donchian high1.15

Donchian low0.8800

AVWAP (52w high)1.68

vs AVWAP high-37.19%

AVWAP (52w low)1.14

vs AVWAP low-7.24%

OBV trendDown

Chaikin MF (20)-0.06

Today vs 20d1.71×

Avg vol (14d)559.41K

Avg vol (20d)635.48K

Avg $ vol (20d)630.52K

Market cap100.32M

RS 3m (vs SPY)-12.59%

RS 6m (vs SPY)-6.08%

RS line new highNo

Trend template1/8

Technical rank33.0

1 week+18.34%

1 month-3.21%

3 months-12.81%

6 months-0.47%

1 year+55.83%

YTD-28.23%

P/E-4.27

P/B3.04

P/S—

P/FCF-4.08

EPS-0.3200

Div yield—

ROE-71.12%

ROA-60.38%

Debt/Eq—

Current7.03

EV/EBITDA-1.39

Gross margin—

Net margin—

Rev growth—

EPS growth30.86%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value66.31M

Revenue—

Net income-3.93M

Gross profit—

Free cash flow-24.59M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out89.5M

Employees14

ListedFri, Oct 8, 2021

Free float79.6M

Float %90.2%

Short interest9.68M

Days to cover4.8d

Short volume15.7%

Squeeze score59 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank33.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.49

Support0.8801

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CGTX

All disclosures →

No recent disclosed trades by Congress in CGTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CGTX · 8 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
RICHSTONE ELLEN B Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Wallace Peggy Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Monia Brett P Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Khattar Jack A. Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Fletcher Aaron G.L. Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Doyle John Brendan Chief Financial Officer · Common Stock · 2026-05-01	Tax	8.57K	$11K	2026-05-01	2026-05-04
Doyle John Brendan Chief Financial Officer · Common Stock · 2026-04-16	Buy	10K	$11K	2026-04-16	2026-04-20
Ricciardi Lisa CEO & President · Common Stock · 2026-04-16	Buy	9.18K	$10K	2026-04-16	2026-04-20
Caggiano Anthony Chief Medical Officer · Common Stock · 2026-04-16	Buy	10K	$11K	2026-04-16	2026-04-20
Ricciardi Lisa CEO & President · Common Stock · 2026-04-16	Other	—	—	2026-04-16	2026-04-20

SEC filings

EDGAR filings in CGTX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.